Faculty, Staff and Student Publications
Publication Date
2-28-2023
Journal
Langenbeck's Archives of Surgery
DOI
10.1007/s00423-022-02732-0
PMID
36853519
PMCID
PMC12105878
PubMedCentral® Posted Date
5-26-2025
PubMedCentral® Full Text Version
Author MSS
Abstract
Introduction: Appendiceal neoplasms have a propensity for peritoneal dissemination. The standard of care for select individuals is CRS/HIPEC. In the current 8th AJCC Staging system, a finding of only intraperitoneal acellular mucin (M1a) is classified as Stage IVa. There is concern that the current AJCC system may over-stage patients.
Methods: This was a single-institution retrospective review of 164 cases of mucinous appendiceal neoplasm. Patients undergoing CRS/HIPEC with M1a disease were compared to patients with peritoneal deposits containing tumor cells (well-differentiated adenocarcinoma; low-grade mucinous carcinoma peritonei-M1b,G1). Overall and recurrence-free survival were assessed.
Results: Median age was 51 years, 70% were female, and 75% White. Sixty-four patients had M1a disease and 100 M1b,G1 disease. M1a disease had a lower median PCI score (11 vs. 20, p = .0001) and a higher rate of complete CRS (62% vs. 50%, p = .021). Median follow-up was 7.6 years (IQR 5.6-10.5 years). For M1a disease, there were no recurrences and only one patient died during the study interval. In comparison, for M1b disease, 66/100 (66%) recurred with a 5-year RFS of 40.5% (HR 8.0, 95% CI 4.9-15.1, p < .0001), and 31/100 (31%) died with a 5-year OS of 84.8% (HR 4.5, 95% CI 2.2-9.2, p < .0001).
Conclusions: Acellular mucin (M1a disease) after CRS/HIPEC for appendiceal neoplasm is associated with longer OS and RFS compared to M1b, G1 disease. Current AJCC staging does not accurately reflect the differing outcomes of these two patient populations. The presence of acellular mucin in the peritoneal cavity should not be perceived as a metastatic equivalent.
Keywords
Humans, Female, Middle Aged, Male, Mucins, Appendiceal Neoplasms, Hyperthermic Intraperitoneal Chemotherapy, Cytoreduction Surgical Procedures, Percutaneous Coronary Intervention, Prognosis, Appendiceal cancer, HIPEC
Published Open-Access
yes
Recommended Citation
Erstad, Derek J; Robinson, Kristen A; Beaty, Karen; et al., "Prognostic Significance of Acellular Mucin in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for Appendiceal Neoplasms" (2023). Faculty, Staff and Student Publications. 4937.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/4937
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons